Merck Animal Health To Acquire TARGAN To Expand Poultry Technology Portfolio

India, June 11 -- Merck Animal Health, a division of Merck & Co. (MRK), on Thursday announced a definitive agreement to acquire TARGAN, a privately held developer of biodevice solutions for the poultry industry, for undisclosed consideration.

The transaction is expected to close in the third quarter of 2026.

The acquisition is expected to expand Merck Animal Health's poultry portfolio with TARGAN's biodevice technologies,

The expansion includes WingScan, an automated chick sex-sorting system that uses vision technology and proprietary algorithms to process up to 160,000 chicks per hour.

googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });

The deal also adds high-speed precision ocular spray technology fo...